The global market for Non-invasive Prenatal Genetic Testing was valued at US$ 8419 million in the year 2024 and is projected to reach a revised size of US$ 20310 million by 2031, growing at a CAGR of 13.6% during the forecast period.

Non-invasive Prenatal Genetic Testing Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-invasive Prenatal Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Prenatal Genetic Testing.

The Non-invasive Prenatal Genetic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-invasive Prenatal Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-invasive Prenatal Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-invasive Prenatal Genetic Testing Market Report

Report Metric	Details
Report Name	Non-invasive Prenatal Genetic Testing Market
Accounted market size in year	US$ 8419 million
Forecasted market size in 2031	US$ 20310 million
CAGR	13.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	NIPT Basic Edition NIPT Plus
Segment by Application	Elderly Primipara Assisted Reproductive Population Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Labcorp, Illumina, Roche, Natera, Premaitha Health, The Beijing Genomics Institute, Berry Genomics, Daan Gene, Annoroad, CapitalBio Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-invasive Prenatal Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-invasive Prenatal Genetic Testing Market growing?

Ans: The Non-invasive Prenatal Genetic Testing Market witnessing a CAGR of 13.6% during the forecast period 2025-2031.

What is the Non-invasive Prenatal Genetic Testing Market size in 2031?

Ans: The Non-invasive Prenatal Genetic Testing Market size in 2031 will be US$ 20310 million.

Who are the main players in the Non-invasive Prenatal Genetic Testing Market report?

Ans: The main players in the Non-invasive Prenatal Genetic Testing Market are Labcorp, Illumina, Roche, Natera, Premaitha Health, The Beijing Genomics Institute, Berry Genomics, Daan Gene, Annoroad, CapitalBio Technology

What are the Application segmentation covered in the Non-invasive Prenatal Genetic Testing Market report?

Ans: The Applications covered in the Non-invasive Prenatal Genetic Testing Market report are Elderly Primipara, Assisted Reproductive Population, Others

What are the Type segmentation covered in the Non-invasive Prenatal Genetic Testing Market report?

Ans: The Types covered in the Non-invasive Prenatal Genetic Testing Market report are NIPT Basic Edition, NIPT Plus

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 NIPT Basic Edition

1.2.3 NIPT Plus

1.3 Market by Application

1.3.1 Global Non-invasive Prenatal Genetic Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Elderly Primipara

1.3.3 Assisted Reproductive Population

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-invasive Prenatal Genetic Testing Market Perspective (2020-2031)

2.2 Global Non-invasive Prenatal Genetic Testing Growth Trends by Region

2.2.1 Global Non-invasive Prenatal Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Non-invasive Prenatal Genetic Testing Historic Market Size by Region (2020-2025)

2.2.3 Non-invasive Prenatal Genetic Testing Forecasted Market Size by Region (2026-2031)

2.3 Non-invasive Prenatal Genetic Testing Market Dynamics

2.3.1 Non-invasive Prenatal Genetic Testing Industry Trends

2.3.2 Non-invasive Prenatal Genetic Testing Market Drivers

2.3.3 Non-invasive Prenatal Genetic Testing Market Challenges

2.3.4 Non-invasive Prenatal Genetic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-invasive Prenatal Genetic Testing Players by Revenue

3.1.1 Global Top Non-invasive Prenatal Genetic Testing Players by Revenue (2020-2025)

3.1.2 Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Players (2020-2025)

3.2 Global Non-invasive Prenatal Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Non-invasive Prenatal Genetic Testing Revenue

3.4 Global Non-invasive Prenatal Genetic Testing Market Concentration Ratio

3.4.1 Global Non-invasive Prenatal Genetic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Prenatal Genetic Testing Revenue in 2024

3.5 Global Key Players of Non-invasive Prenatal Genetic Testing Head office and Area Served

3.6 Global Key Players of Non-invasive Prenatal Genetic Testing, Product and Application

3.7 Global Key Players of Non-invasive Prenatal Genetic Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-invasive Prenatal Genetic Testing Breakdown Data by Type

4.1 Global Non-invasive Prenatal Genetic Testing Historic Market Size by Type (2020-2025)

4.2 Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Type (2026-2031)

5 Non-invasive Prenatal Genetic Testing Breakdown Data by Application

5.1 Global Non-invasive Prenatal Genetic Testing Historic Market Size by Application (2020-2025)

5.2 Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Non-invasive Prenatal Genetic Testing Market Size (2020-2031)

6.2 North America Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)

6.4 North America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-invasive Prenatal Genetic Testing Market Size (2020-2031)

7.2 Europe Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)

7.4 Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size (2020-2031)

8.2 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-invasive Prenatal Genetic Testing Market Size (2020-2031)

9.2 Latin America Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)

9.4 Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size (2020-2031)

10.2 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Labcorp

11.1.1 Labcorp Company Details

11.1.2 Labcorp Business Overview

11.1.3 Labcorp Non-invasive Prenatal Genetic Testing Introduction

11.1.4 Labcorp Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)

11.1.5 Labcorp Recent Development

11.2 Illumina

11.2.1 Illumina Company Details

11.2.2 Illumina Business Overview

11.2.3 Illumina Non-invasive Prenatal Genetic Testing Introduction

11.2.4 Illumina Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)

11.2.5 Illumina Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Non-invasive Prenatal Genetic Testing Introduction

11.3.4 Roche Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)

11.3.5 Roche Recent Development

11.4 Natera

11.4.1 Natera Company Details

11.4.2 Natera Business Overview

11.4.3 Natera Non-invasive Prenatal Genetic Testing Introduction

11.4.4 Natera Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)

11.4.5 Natera Recent Development

11.5 Premaitha Health

11.5.1 Premaitha Health Company Details

11.5.2 Premaitha Health Business Overview

11.5.3 Premaitha Health Non-invasive Prenatal Genetic Testing Introduction

11.5.4 Premaitha Health Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)

11.5.5 Premaitha Health Recent Development

11.6 The Beijing Genomics Institute

11.6.1 The Beijing Genomics Institute Company Details

11.6.2 The Beijing Genomics Institute Business Overview

11.6.3 The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Introduction

11.6.4 The Beijing Genomics Institute Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)

11.6.5 The Beijing Genomics Institute Recent Development

11.7 Berry Genomics

11.7.1 Berry Genomics Company Details

11.7.2 Berry Genomics Business Overview

11.7.3 Berry Genomics Non-invasive Prenatal Genetic Testing Introduction

11.7.4 Berry Genomics Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)

11.7.5 Berry Genomics Recent Development

11.8 Daan Gene

11.8.1 Daan Gene Company Details

11.8.2 Daan Gene Business Overview

11.8.3 Daan Gene Non-invasive Prenatal Genetic Testing Introduction

11.8.4 Daan Gene Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)

11.8.5 Daan Gene Recent Development

11.9 Annoroad

11.9.1 Annoroad Company Details

11.9.2 Annoroad Business Overview

11.9.3 Annoroad Non-invasive Prenatal Genetic Testing Introduction

11.9.4 Annoroad Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)

11.9.5 Annoroad Recent Development

11.10 CapitalBio Technology

11.10.1 CapitalBio Technology Company Details

11.10.2 CapitalBio Technology Business Overview

11.10.3 CapitalBio Technology Non-invasive Prenatal Genetic Testing Introduction

11.10.4 CapitalBio Technology Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)

11.10.5 CapitalBio Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Natera

Premaitha Health

The Beijing Genomics Institute

Berry Genomics

DAAN Gene

Annoroad

CapitalBio Technology

Illumina Inc

LabCorp

List of Tables

Table 1. Global Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of NIPT Basic Edition

Table 3. Key Players of NIPT Plus

Table 4. Global Non-invasive Prenatal Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Non-invasive Prenatal Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Non-invasive Prenatal Genetic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Non-invasive Prenatal Genetic Testing Market Share by Region (2020-2025)

Table 8. Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Non-invasive Prenatal Genetic Testing Market Share by Region (2026-2031)

Table 10. Non-invasive Prenatal Genetic Testing Market Trends

Table 11. Non-invasive Prenatal Genetic Testing Market Drivers

Table 12. Non-invasive Prenatal Genetic Testing Market Challenges

Table 13. Non-invasive Prenatal Genetic Testing Market Restraints

Table 14. Global Non-invasive Prenatal Genetic Testing Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Non-invasive Prenatal Genetic Testing Market Share by Players (2020-2025)

Table 16. Global Top Non-invasive Prenatal Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Prenatal Genetic Testing as of 2024)

Table 17. Ranking of Global Top Non-invasive Prenatal Genetic Testing Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Non-invasive Prenatal Genetic Testing Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Non-invasive Prenatal Genetic Testing, Headquarters and Area Served

Table 20. Global Key Players of Non-invasive Prenatal Genetic Testing, Product and Application

Table 21. Global Key Players of Non-invasive Prenatal Genetic Testing, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-invasive Prenatal Genetic Testing Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Type (2020-2025)

Table 25. Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Type (2026-2031)

Table 27. Global Non-invasive Prenatal Genetic Testing Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Application (2020-2025)

Table 29. Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Application (2026-2031)

Table 31. North America Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Labcorp Company Details

Table 47. Labcorp Business Overview

Table 48. Labcorp Non-invasive Prenatal Genetic Testing Product

Table 49. Labcorp Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)

Table 50. Labcorp Recent Development

Table 51. Illumina Company Details

Table 52. Illumina Business Overview

Table 53. Illumina Non-invasive Prenatal Genetic Testing Product

Table 54. Illumina Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)

Table 55. Illumina Recent Development

Table 56. Roche Company Details

Table 57. Roche Business Overview

Table 58. Roche Non-invasive Prenatal Genetic Testing Product

Table 59. Roche Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)

Table 60. Roche Recent Development

Table 61. Natera Company Details

Table 62. Natera Business Overview

Table 63. Natera Non-invasive Prenatal Genetic Testing Product

Table 64. Natera Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)

Table 65. Natera Recent Development

Table 66. Premaitha Health Company Details

Table 67. Premaitha Health Business Overview

Table 68. Premaitha Health Non-invasive Prenatal Genetic Testing Product

Table 69. Premaitha Health Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)

Table 70. Premaitha Health Recent Development

Table 71. The Beijing Genomics Institute Company Details

Table 72. The Beijing Genomics Institute Business Overview

Table 73. The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Product

Table 74. The Beijing Genomics Institute Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)

Table 75. The Beijing Genomics Institute Recent Development

Table 76. Berry Genomics Company Details

Table 77. Berry Genomics Business Overview

Table 78. Berry Genomics Non-invasive Prenatal Genetic Testing Product

Table 79. Berry Genomics Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)

Table 80. Berry Genomics Recent Development

Table 81. Daan Gene Company Details

Table 82. Daan Gene Business Overview

Table 83. Daan Gene Non-invasive Prenatal Genetic Testing Product

Table 84. Daan Gene Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)

Table 85. Daan Gene Recent Development

Table 86. Annoroad Company Details

Table 87. Annoroad Business Overview

Table 88. Annoroad Non-invasive Prenatal Genetic Testing Product

Table 89. Annoroad Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)

Table 90. Annoroad Recent Development

Table 91. CapitalBio Technology Company Details

Table 92. CapitalBio Technology Business Overview

Table 93. CapitalBio Technology Non-invasive Prenatal Genetic Testing Product

Table 94. CapitalBio Technology Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)

Table 95. CapitalBio Technology Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Non-invasive Prenatal Genetic Testing Picture

Figure 2. Global Non-invasive Prenatal Genetic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Non-invasive Prenatal Genetic Testing Market Share by Type: 2024 VS 2031

Figure 4. NIPT Basic Edition Features

Figure 5. NIPT Plus Features

Figure 6. Global Non-invasive Prenatal Genetic Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Non-invasive Prenatal Genetic Testing Market Share by Application: 2024 VS 2031

Figure 8. Elderly Primipara Case Studies

Figure 9. Assisted Reproductive Population Case Studies

Figure 10. Others Case Studies

Figure 11. Non-invasive Prenatal Genetic Testing Report Years Considered

Figure 12. Global Non-invasive Prenatal Genetic Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Non-invasive Prenatal Genetic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Non-invasive Prenatal Genetic Testing Market Share by Region: 2024 VS 2031

Figure 15. Global Non-invasive Prenatal Genetic Testing Market Share by Players in 2024

Figure 16. Global Top Non-invasive Prenatal Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Prenatal Genetic Testing as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Non-invasive Prenatal Genetic Testing Revenue in 2024

Figure 18. North America Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)

Figure 20. United States Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)

Figure 24. Germany Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Share by Region (2020-2031)

Figure 32. China Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)

Figure 40. Mexico Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)

Figure 44. Turkey Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Labcorp Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)

Figure 48. Illumina Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)

Figure 49. Roche Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)

Figure 50. Natera Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)

Figure 51. Premaitha Health Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)

Figure 52. The Beijing Genomics Institute Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)

Figure 53. Berry Genomics Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)

Figure 54. Daan Gene Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)

Figure 55. Annoroad Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)

Figure 56. CapitalBio Technology Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions